Walleye Trading LLC Syndax Pharmaceuticals Inc Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$19.35 - $22.31 $522,798 - $602,771	-27,018 Reduced 73.63%	9,677 $202,000
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $532,160 - $746,466	25,758 Added 235.51%	36,695 $774,000
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $225,739 - $286,986	10,937 New	10,937 $278,000
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $1.65 Million - $2.47 Million	-111,382 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $1.52 Million - $2.24 Million	99,783 Added 860.27%	111,382 $2.44 Million
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $160,878 - $229,660	11,599 New	11,599 $222,000
Q2 2019 Aug 14, 2019	SELL	$4.9 - $9.31 $54,742 - $104,011	-11,172 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.26 - $6.86 $47,592 - $76,639	11,172 New	11,172 $59,000

230

90M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.